Somatic Copy Number Alterations by Whole Exome Sequencing Reveals YWHAZ and PTK2 as Potential Therapeutic Targets in Castration Resistant Prostate Cancer

被引：0
|
作者：
Ruenauver, K.
Menon, R.
Deng, M.
Kunze, F.
Bohm, D.
Vogel, W.
Scheble, V.
Fend, F.
Kristiansen, G.
Wernert, N.
Oberbeckmann, N.
Biskup, S.
Rubin, M.
Shaikhibrahim, Z.
Perner, S.
机构：
[1] Univ Hosp Bonn, Inst Pathol, Bonn, Germany
[2] Univ Tubingen Hosp, Tubingen, Germany
[3] CeGaT GmbH, Tubingen, Germany
[4] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA
[5] Univ Tubingen Hosp, Inst Pathol, Tubingen, Germany
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1017
引用
收藏
页码：245A / 245A
页数：1
相关论文
共 50 条
  • [41] Whole genome sequencing of 378 prostate cancer metastases reveals tissue selectivity for mismatch deficiency with potential therapeutic implications
    Vis, Daniel J.
    Palit, Sander A. L.
    Corradi, Marie
    Cuppen, Edwin
    Mehra, Niven
    Lolkema, Martijn P.
    Wessels, Lodewyk F. A.
    van der Heijden, Michiel S.
    Zwart, Wilbert
    Bergman, Andries M.
    GENOME MEDICINE, 2025, 17 (01):
  • [42] RNA sequencing analysis of taxane-resistant prostate cancer cells reveals potential candidate genes for therapeutic targeting
    Cajigas-Du Ross, Christina K.
    Woods-Burnham, Leanne
    Ramirez, Joshua
    Chen, Xin
    Wang, Charles
    Casiano, Carlos A.
    CANCER RESEARCH, 2018, 78 (13)
  • [43] ZBTB46, SPDEF, and ETV6: Novel Potential Biomarkers and Therapeutic Targets in Castration-Resistant Prostate Cancer
    Fararjeh, AbdulFattah Salah
    Liu, Yen-Nien
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (11)
  • [44] Prevalence and tissue concordance of BRCA2 copy number loss evaluated by single-cell, shallow whole genome sequencing of circulating tumor cells (CTCs) in castration-resistant prostate cancer (CRPC).
    Barnett, Ethan
    Schonhoft, Joseph
    Schultz, Nikolaus D.
    Lee, Jerry
    Zaidi, Samir
    Abida, Wassim
    Carmichael, Taylor
    Dago, Angel E.
    Solit, David B.
    Wenstrup, Rick
    Scher, Howard, I
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] Development and Validation of Whole Exome Sequencing Test Version 1 (EXaCT-1) for Simultaneous Detection of Point Mutation, Indels and Copy Number Alterations in Cancer Specimens
    Rennert, H.
    Xiang, J.
    Tan, A. Y.
    Eng, K.
    Zhang, T.
    Kim, R.
    Tam, W.
    Beltran, H.
    Robinson, B. D.
    Mosquera, J.
    Fernandes, H.
    Campagne, F.
    Sboner, A.
    Elemento, O.
    Rubin, M. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 748 - 749
  • [46] FULL EXOME SEQUENCING, COPY NUMBER VARIATION AND TRANSCRIPTOME ANALYSES REVEALS DIVERSITY AND MUTATIONAL EVOLUTION IN A LONGITUDINAL SERIES OF SURGICAL PROSTATE CANCER BONE METASTASES FROM A PATIENT WITH PROGRESSIVELY THERAPY-RESISTANT CANCER.
    Jamieson, Christina
    Muldong, Michelle
    Liss, Michael A.
    Park, Seung Chol
    Mendoza, Theresa
    Gallegos, Abigail
    Edsall, Lee
    Nseyo, Unwanaobong
    Miakicheva, Olga
    Burton, Brittany
    Burner, Danielle
    Strasner, Amy
    Kane, Christopher J.
    Kulidjian, Anna A.
    Gaasterland, Theresa
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1146 - E1147
  • [47] Genome-wide CRISPR-Cas9 screening identifies genetic vulnerabilities and potential therapeutic targets in castration resistant prostate cancer
    Haldrup, Jakob
    Schmidt, Linnea
    Pedersen, Jakob S.
    Sorensen, Karina D.
    CANCER RESEARCH, 2018, 78 (13)
  • [48] Dynamics of plasma tumour DNA and copy number alterations in advanced metastatic castration-resistant prostate cancer (mCRPC) patients treated with cabazitaxel: A prospective biomarker trial
    Brighi, N.
    Wetterskog, D.
    Gurioli, G.
    Orlando, F.
    Conteduca, V.
    Casadei, C.
    Lolli, C.
    Giunta, E. F.
    Bleve, S.
    Vainauskas, O.
    Basso, U.
    Pierantoni, F.
    Fornarini, G.
    Mosca, A.
    Nicodemo, M.
    Banna, G. L.
    Ulivi, P.
    Demichelis, F.
    De Giorgi, U. F. F.
    Attard, G.
    ANNALS OF ONCOLOGY, 2023, 34 : S979 - S979
  • [49] Circulating tumor DNA-targeted sequencing to reveal germline and somatic alterations that can guide decision-making in metastatic castration-resistant prostate cancer
    Dong, Baijun
    Fan, Liancheng
    Yang, Bin
    Chen, Wei
    Li, Yonghong
    Wu, Kaijie
    Zhang, Fengbo
    Li, Lei
    Yao, Xudong
    Xue, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [50] Calpain and AR-V7: Two potential therapeutic targets to overcome acquired docetaxel resistance in castration-resistant prostate cancer cells
    Liu, Lei
    Lou, Ning
    Li, Xiang
    Xu, Guanghua
    Ruan, Hailong
    Xia, Wen
    Qiu, Bin
    Bao, Lin
    Yuan, Changfei
    Huang, Xinmian
    Wang, Keshan
    Cao, Qi
    Chen, Ke
    Yang, Hongmei
    Zhang, Xiaoping
    ONCOLOGY REPORTS, 2017, 37 (06) : 3651 - 3659
12345